-
Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD. Thorax. 2020 Feb;75(2):116-122.
Shimizu K, Tanabe N, Tho NV, Suzuki M, Makita H, Sato S, Muro S, Mishima M, Hirai T, Ogawa E, Nakano Y, Konno S, Nishimura M
-
Serum Alpha-1 Antitrypsin Levels and the Clinical Course of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2019 Dec 10;14:2885-2893.
Takei N, Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, Nishimura M
-
Annual change in FEV(1) in elderly 10-year survivors with established chronic obstructive pulmonary disease. Sci Rep. 2019 Feb 14;9(1):2073.
Makita H, Suzuki M, Konno S, Shimizu K, Nasuhara Y, Nagai K, Akiyama Y, Fuke S, Saito H, Igarashi T, Takeyabu K, Nishimura M
-
Impact of Abdominal Visceral Adiposity on Adult Asthma Symptoms. J Allergy Clin Immunol Pract. 2018 Nov 24.
Goudarzi H, Konno S, Kimura H, Makita H, Matsumoto M, Takei N, Kimura H, Shimizu K, Suzuki M, Ito YM, Nishimura M; Hi-CARAT investigators.
-
Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up. Clin Exp Allergy. 2018 Sep;48(9):1137-1146.
Kimura H, Konno S, Makita H, et al
-
Transfer coefficients better reflect emphysematous changes than carbon monoxide diffusing capacity in obstructive lung diseases. J Appl Physiol. 2018 Jul 1;125(1):183-189.
Shimizu K, Konno S, Makita H, et al
-
Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int. 2018 Jul;67(3):357-363.
Kimura H, Konno S, Makita H, Taniguchi N, Kimura H, Goudarzi H, Shimizu K, Suzuki M, Shijubo N, Shigehara K, Ono J, Izuhara K, Ito YM, Nishimura M
-
Relationship of annual change in bone mineral density with extent of emphysematous lesions and pulmonary function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018 Feb 20;13:639-644.
Goto K, Ogawa E, Shimizu K, Makita H, Suzuki H, Kawata Y, Niki N, Nishimura M,Nakano Y
-
Distinct Phenotypes of Smokers with Fixed Airflow Limitation Identified by Cluster Analysis of Severe Asthma. Ann Am Thorac Soc. 2018 Jan;15(1):33-41.
Konno S, Taniguchi N, Makita H, Nakamaru Y, Shimizu K, Shijubo N, Fuke S, Takeyabu K, Oguri M, Kimura H, Maeda Y, Suzuki M, Nagai K, Ito YM, Wenzel SE, Nishimura M; HiCARAT Investigators.
-
Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation. Respir Med. 2017 Jun;127:14-20.
Konno S, Makita H, Suzuki M, Shimizu K, Kimura H, Kimura H, Nishimura M,Hokkaido COPD Cohort Study Investigators.
-
Computed tomography (CT)-assessed bronchodilation induced by inhaled indacaterol and glycopyrronium/indacaterol in COPD. Respir Med. 2016 Oct;119:70-77.
Shimizu K, Seto R, Makita H, Suzuki M, Konno S, Ito YM, Kanda R, Ogawa E, Nakano Y, Nishimura M
-
Asthma-like Features and Clinical Course of COPD: An Analysis From the Hokkaido COPD Cohort Study. Am J Respir Crit Care Med. 2016 Dec 1;194(11):1358-1365.
Suzuki M, Makita H, Konno S, Shimizu K, Kimura H, Kimura H, Nishimura M; Hokkaido COPD cohort study investigators.
-
Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:745-57.
Nagai N, Makita H, Suzuki M, Shimizu K, Konno S, Ito YM, Nishimura M, On behalf of the Hokkaido COPD Cohort Study Investigators
-
Regional bronchodilator response assessed by computed tomography in chronic obstructive pulmonary disease. Eur J Radiol. 2015 Jun;84(6):1196-201.
Shimizu K, Makita H, Hasegawa M, Kimura H, Fuke S, Nagai K, Yoshida T, Suzuki M, Konno S, Ito YM, Nishimura M
-
Danish Lung Cancer Screening Trial Investigators. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 ;11:1511-9.
Suzuki M, Makita H, Östling J, Thomsen LH, Konno S, Nagai K, Shimizu K, Pedersen JH, Ashraf H, Bruijnzeel PL, Maciewicz RA, Nishimura M; Hokkaido COPD Cohort Study
-
The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma. Pharmacogenet Genomics. 2014 May;24(5):246-55.
Konno S, Hizawa N, Makita H, Shimizu K, Sakamoto T, Kokubu F, Saito T, Endo T, Ninomiya H, Iijima H, Kaneko N, Ito YM, Nishimura M; J-Blossom Study Group
-
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014 May;43(5):1289-97.
Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M; Hokkaido COPD Cohort Study Investigators
-
Effect of lung volume on airway luminal area assessed by computed tomography in chronic obstructive pulmonary disease. PLoS One. 2014 Feb 28;9(2):e90040.
Kambara K, Shimizu K, Makita H, Hasegawa M, Nagai K, Konno S, Nishimura M
-
Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis. 2013;8:31-9.
Oh YM, Bhome AB, Boonsawat W, Gunasekera KD, Madegedara D, Idolor L, Roa C, Kim WJ, Kuo HP, Wang CH, Lan le TT, Loh LC, Ong CK, Ng A, Nishimura M, Makita H, Silverman EK, Lee JS, Yang T, Lin Y, Wang C, Lee SD
-
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185(1):44-52.
Makita H, Nishimura M, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito Y, Fuke S, Igarashi T, Akiyama Y, Ogura S; Hokkaido COPD Cohort Study Investigators
-
Konno S, Makita H, Hasegawa M, Nasuhara Y, Nagai K, Betsuyaku T, Hizawa N, Nishimura M
Konno S, Makita H, Hasegawa M, Nasuhara Y, Nagai K, Betsuyaku T, Hizawa N, Nishimura M
-
Comparison of airway remodelling assessed by computed tomography in asthma and COPD. Respir Med. 2011 Sep;105(9):1275-83.
Shimizu K, Hasegawa M, Makita H, Nasuhara Y, Konno S, Nishimura M
-
Airflow limitation and airway dimensions assessed per bronchial generation in older asthmatics. Respir Med. 2010 Dec;104(12):1809-16.
Shimizu K, Hasegawa M, Makita H, Nasuhara Y, Konno S, Nishimura M
-
Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax. 2009 Apr;64(4):332-8.
Hasegawa M, Makita H, Nasuhara Y, Odajima N, Nagai K, Ito Y, Betsuyaku T, Nishimura M
-
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients. Eur Respir J. 2008 Aug;32:372-8. Epub 2008 Apr 2.
Hizawa N, Makita H, Nasuhara Y, Hasegawa M, Nagai K, Ito Y, Betsuyaku T, Konno S, Nishimura M; Hokkaido COPD Cohort Study Group
-
Characterization of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007 Nov;62(11):932-7.
Makita H, Nasuhara Y, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M
-
Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest. 2007 Nov;132(5):1485-92. Epub 2007 Sep 21.
Hizawa N, Makita H, Nasuhara Y, Betsuyaku T, Itoh Y, Nagai K, Hasegawa M, Nishimura M
-
Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Jun 15;173(12):1309-15.
Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, Ito Y, Betsuyaku T, Nishimura M
-
Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells. Respirology. 2003 Dec;8(4):467-72.
Itoh A, Nishihira J, Makita H, Miyamoto K, Yamaguchi E, Nishimura M
-
Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest. 2002 Nov;122(5):1686-94.
Saito H, Nishimura M, Shibuya E, Makita H, Tsujino I, Miyamoto K, Kawakami Y
-
Plasma concentration of adenosine during normoxia and moderate hypoxia in humans.Am J Respir Crit Care Med. 1999 ;159(3):1014-1018.
Saito H, Nishimura M, Shinano H, Makita H, Tsujino I, Shibuya E, Sato F, Miyamoto K, Kawakami Y
-
Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med. 1998 Aug;158(2):573-9.
Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, Nishihira J, Kawakami Y
-
Production of nitric oxide (NO) in intrathoracic airways of normal humans. Am J Respir Crit Care Med. 1996 Nov;154(5):1370-4.
Tsujino I, Miyamoto K, Nishimura M, Shinano H, Makita H, Saito S, Nakano T, Kawakami Y
-
Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab. 1994; 78: 393-397
Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K
-
Chronological change in pulmonary vascular response to hypoxia in hepatopulmonary syndrome. Respiration. 2012;84(3):242-5.
Tanino Y, Makita H, Tsujino I, Shinano H, Nishimura M
-
[A case of sarcoidosis complicated by primary Sjogren's syndrome] Nihon Kokyuki Gakkai Zasshi. 2002 Aug;40(8):686-91.
Fuke S, Yamaguchi E, Makita H, Morikawa T, Nishimura M
-
Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma? Respiration. 2000;67(6):645-51.
Tsujino I, Nishimura M, Kamachi A, Makita H, Munakata M, Miyamoto K, Kawakami Y
-
Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea. Am J Respir Crit Care Med. 1997 Apr;155(4):1482-5.
Hommura F, Nishimura M, Oguri M, Makita H, Hosokawa K, Saito H, Miyamoto K, Kawakami Y
-
A family with complete deficiency of plasma cholesteryl ester transfer protein activities. Intern. Med. 1994; 33: 432-436.
Makita H, Tsuji M, Furuya Y, Tsutsihashi K, Akita H, Chiba H